Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Therapeutic efficacy of to-be-marketed cholic acid capsules vs current formulation in children with inborn errors of bile acid synthesis
2011-004491-10Phase 3
- Sponsor
- Asklepion Pharmaceuticals
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of cholic acid in congenital bile acid synthesis disorder (CBASD) (2 arms), sponsored by Asklepion Pharmaceuticals. Primary endpoint: Primary therapeutic efficacy comparison.
02
Drugs
cholic acid
03
Conditions
congenital bile acid synthesis disorder (CBASD)
Beyond the preview
Go deeper on 2011-004491-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-004491-10.